EP 2250185 A1 20101117 - NOVEL LUPANE DERIVATIVES
Title (en)
NOVEL LUPANE DERIVATIVES
Title (de)
NEUE LUPANDERIVATE
Title (fr)
NOUVEAUX DÉRIVÉS DE LUPANE
Publication
Application
Priority
- CA 2008002291 W 20081223
- US 1875908 P 20080103
- US 3966008 P 20080326
Abstract (en)
[origin: WO2009082819A1] The invention relates to 21-keto triterpene compounds of formula (I): wherein R1, X, and Y are as defined herein, and pharmaceutically acceptable salts and solvates thereof. These compounds exhibit significant anti-HIV activity. Thus, the invention also relates to methods for prevention or treatment of HIV infections by administering therapeutically effective amounts of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof to a subject in need of such treatment.
IPC 8 full level
C07J 63/00 (2006.01); A61K 31/575 (2006.01); A61K 31/58 (2006.01); A61K 38/55 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); C07J 41/00 (2006.01); C07J 43/00 (2006.01); C07J 53/00 (2006.01)
CPC (source: EP)
A61K 31/575 (2013.01); A61K 31/58 (2013.01); A61K 38/05 (2013.01); A61K 38/55 (2013.01); A61K 45/06 (2013.01); A61P 31/12 (2017.12); A61P 31/18 (2017.12)
C-Set (source: EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2009082819 A1 20090709; WO 2009082819 A8 20090903; WO 2009082819 A8 20091022; AU 2008342537 A1 20090709; CA 2711424 A1 20090709; CN 101981047 A 20110223; EP 2250185 A1 20101117; EP 2250185 A4 20111116; JP 2011508748 A 20110317; MX 2010007375 A 20100930
DOCDB simple family (application)
CA 2008002291 W 20081223; AU 2008342537 A 20081223; CA 2711424 A 20081223; CN 200880127527 A 20081223; EP 08869088 A 20081223; JP 2010540997 A 20081223; MX 2010007375 A 20081223